Market Overview

UPDATE: Cantor Fitzgerald Initiates Acadia Healthcare at Buy on Favorable Industry Trends

Related ACHC
Acadia Healthcare Q4 Earnings Preview
Earnings Scheduled For February 21, 2018
Courage Capital Management Llc Buys Acadia Healthcare Co Inc, Michael Kors Holdings, SPDR ... (GuruFocus)

Cantor Fitzgerald analyst Joseph D. France published a report on Acadia Healthcare (NASDAQ: ACHC), initiating coverage with a Buy rating and $35 price target.

Cantor Fitzgerald reported that, “We are initiating coverage of Acadia Healthcare with a BUY rating and $35 price target that values the company at roughly twice the acute care industry average, on both a P/E and EV/EBITDA (2014) basis, because of the more favorable regulatory environment for behavioral health services and the faster growth we expect Acadia to deliver as it capitalizes on changes in the market. Relative to other facilities-based behavioral health providers, we believe that Acadia is advantaged because it is the largest freestanding provider in the field. Our diluted EPS estimates are $1.00 in 2013 and $1.25 in 2014, compared with an adjusted $0.66 the company reported in 2012. Our $35 price target assumes that the stock can achieve a valuation of 11.6x our 2014 EBITDA estimate, which we believe potentially reflects Acadia's rapid growth in 2011-12, its competitive advantage, and industry trends that we believe are favorable.”

Shares of Acadia Healthcare closed at $28.04 on Tuesday.

Latest Ratings for ACHC

Feb 2018BMO CapitalMaintainsOutperformOutperform
Feb 2018BairdMaintainsNeutralNeutral
Feb 2018Credit SuisseMaintainsNeutralNeutral

View More Analyst Ratings for ACHC
View the Latest Analyst Ratings

Posted-In: Cantor FitzgeraldAnalyst Color Initiation Analyst Ratings


Related Articles (ACHC)

View Comments and Join the Discussion!